Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Long-Term Investments (2016 - 2025)

Elevance Health (ELV) has disclosed Long-Term Investments for 17 consecutive years, with $10.8 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 947.25% to $10.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.8 billion through Dec 2025, up 947.25% year-over-year, with the annual reading at $10.8 billion for FY2025, 947.25% up from the prior year.
  • Long-Term Investments for Q4 2025 was $10.8 billion at Elevance Health, up from $10.6 billion in the prior quarter.
  • The five-year high for Long-Term Investments was $10.8 billion in Q4 2025, with the low at $396.0 million in Q1 2021.
  • Average Long-Term Investments over 5 years is $2.5 billion, with a median of $713.0 million recorded in 2023.
  • The sharpest move saw Long-Term Investments decreased 24.55% in 2021, then surged 1151.84% in 2024.
  • Over 5 years, Long-Term Investments stood at $449.0 million in 2021, then rose by 29.4% to $581.0 million in 2022, then surged by 50.77% to $876.0 million in 2023, then grew by 18.15% to $1.0 billion in 2024, then soared by 947.25% to $10.8 billion in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $10.8 billion, $10.6 billion, and $10.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.